AAPG
Price
$17.07
Change
-$0.05 (-0.29%)
Updated
Jun 23, 04:49 PM (EDT)
Capitalization
1.5B
64 days until earnings call
Intraday BUY SELL Signals
RARE
Price
$28.77
Change
-$0.26 (-0.90%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.83B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AAPG vs RARE

AAPG vs RARE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AAPG vs. RARE commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAPG is a Buy and RARE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (AAPG: $17.13 vs. RARE: $29.03)
Brand notoriety: AAPG and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAPG: 283% vs. RARE: 118%
Market capitalization -- AAPG: $1.5B vs. RARE: $2.86B
AAPG [@Biotechnology] is valued at $1.5B. RARE’s [@Biotechnology] market capitalization is $2.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAPG’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • AAPG’s FA Score: 0 green, 5 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, both AAPG and RARE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAPG’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).

  • AAPG’s TA Score: 4 bullish, 2 bearish.
  • RARE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AAPG is a better buy in the short-term than RARE.

Price Growth

AAPG (@Biotechnology) experienced а -1.21% price change this week, while RARE (@Biotechnology) price change was +14.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

AAPG is expected to report earnings on Aug 26, 2026.

RARE is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($2.83B) has a higher market cap than AAPG($1.5B). RARE YTD gains are higher at: 26.217 vs. AAPG (-34.718). RARE has higher annual earnings (EBITDA): -502M vs. AAPG (-1.09B). AAPG has more cash in the bank: 1.66B vs. RARE (413M). RARE has less debt than AAPG: RARE (36M) vs AAPG (1.72B). RARE has higher revenues than AAPG: RARE (670M) vs AAPG (391M).
AAPGRAREAAPG / RARE
Capitalization1.5B2.83B53%
EBITDA-1.09B-502M216%
Gain YTD-34.71826.217-132%
P/E RatioN/AN/A-
Revenue391M670M58%
Total Cash1.66B413M402%
Total Debt1.72B36M4,767%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AAPGRARE
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AAPG
Daily Signal:
Gain/Loss:
RARE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OAIM48.760.30
+0.63%
OneAscent International Equity ETF
YQQQ9.800.06
+0.60%
YieldMax Short N100 Option Inc Strgy ETF
SCYB26.17-0.01
-0.04%
Schwab High Yield Bond ETF
NULC53.94-0.07
-0.12%
Nuveen ESG Large-Cap ETF
QCML29.21-1.10
-3.63%
GraniteShares 2x Long QCOM Daily ETF

AAPG and

Correlation & Price change

A.I.dvisor tells us that AAPG and NGNE have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AAPG and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAPG
1D Price
Change %
AAPG100%
+0.06%
NGNE - AAPG
21%
Poorly correlated
+2.12%
ACTU - AAPG
21%
Poorly correlated
-1.45%
ENVB - AAPG
20%
Poorly correlated
+3.13%
RARE - AAPG
20%
Poorly correlated
+5.79%
BIVI - AAPG
20%
Poorly correlated
+9.94%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been closely correlated with MREO. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if RARE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
+5.79%
MREO - RARE
80%
Closely correlated
+5.59%
VCYT - RARE
46%
Loosely correlated
-0.82%
MLTX - RARE
37%
Loosely correlated
+15.33%
AMRN - RARE
36%
Loosely correlated
-1.15%
RZLT - RARE
35%
Loosely correlated
+2.59%
More